Protalix BioTherapeutics, Inc.

PLXAMEXHealthcare● Active

$1.96

$-0.03(-1.51%)

Market Cap$157920418

P/E Ratio—

52W High$3.19

52W Low$1.32

Avg Volume867K

Open$1.97

Beta0.01

Employees Ownership Insider Trades

Protalix BioTherapeutics, Inc. (PLX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PLX · as of Mar 18, 2026

Latest filing snapshot

226

+13+6.10%vs prior year

Protalix BioTherapeutics, Inc. (PLX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

226

Change (1Y)

+13

Growth % (1Y)

+6.10%

Revenue / Employee

$233.4K

Net Income / Employee

$-29.2K

Market Cap

$158M

PLX Employee Count

2002 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-18	2025-12-31	226	+13	+6.10%
2025-03-17	2024-12-31	213	+5	+2.40%
2024-03-14	2023-12-31	208	+11	+5.58%
2023-02-27	2022-12-31	197	-9	-4.37%
2022-03-31	2021-12-31	206	-1	-0.48%
2021-03-30	2020-12-31	207	+11	+5.61%
2020-03-12	2019-12-31	196	+12	+6.52%
2019-03-18	2018-12-31	184	-6	-3.16%
2018-03-06	2017-12-31	190	-42	-18.10%
2017-03-16	2016-12-31	232	+9	+4.04%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CHRS

Coherus Oncology, Inc.

228$174M #2

PLX

Protalix BioTherapeutics, Inc.YOU

Neonc Technologies Holdings, Inc.

8$90M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PLX peer comparison

About PLX employees

PLX Employees · Headcount

Protalix BioTherapeutics, Inc. (PLX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Protalix BioTherapeutics, Inc. had 226 full-time employees globally. Full-time employees only. Global consolidated headcount.

Protalix BioTherapeutics, Inc. employs 226 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $233,381, reflecting the company's operational efficiency.

Protalix BioTherapeutics, Inc.'s workforce increased by 13 (6.10%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Protalix BioTherapeutics, Inc.'s revenue per employee of $233,381 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

PLX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Protalix BioTherapeutics, Inc. had 226 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Protalix BioTherapeutics, Inc. employee counthow many employees does Protalix BioTherapeutics, Inc. havePLX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-18